The Study Examined the Acute Effects of Wim Hof on Aerobic Training and Cardiodynamics.
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: aerobic exercise where it included walking/ jogging with a controlled speed by the participant, Wim Hof Breathing Method.
- Who it may be relevant to
- Registry conditions: Respiratory Abnormality, Pulmonary, Exercise Training. Basic parameters: 18 years — 25 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Lebanon
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
The Immediate Effect of Adding the Wim Hoff Breathing Method With Aerobic Training on Aerobic Performance and Hemodynamic Response in Smoking Adults
Overview
Researchers will split the sixty healthy smokers in half. Thirty people will serve as a control group and will be asked to walk or jog at a controlled pace for twelve minutes as part of an aerobic exercise program. Separately, 30 people participated in an aerobic exercise session that lasted 12 minutes and involved walking or running at a pace that the participants themselves controlled. WHBM will be done both prior to and subsequent to physical activity. To determine how WHBM affects the experimental group's pre- and post-WHBM heart rates, SpO2, blood pressure, and VO2 max, this study will be conducted.
Detailed description
The study will be a randomized single blinded control trial, sixty healthy smokers will be divided into two groups. a control group of 30 participants will performing a 12-minute aerobic exercise where it included walking/ jogging with a controlled speed by the participant. Another experimental group of 30 participants also, performing a 12-minute aerobic exercise where it included walking/ jogging with a controlled speed by the participant. WHBM will be performed before and after exercises. It will be done to assess the effect of WHBM on heart rate, SpO2, blood pressure and VO2 max that will be monitored before and after WHBM in the experimental group. In addition, Performance will be assessed by observing the difference in distance covered before and after doing the WHBM. Heart rate and SpO2 will be measured using a finger pulse oximeter (Medical Rossmax). Blood pressure will be measured using a sphygmomanometer and VO2 max will be measured using the cooper's test formula in kilometers: "VO2 max = (22.351 x distance in Km) - 11.288"
Interventions
- Other aerobic exercise where it included walking/ jogging with a controlled speed by the participant
participants were asked to listen attentively to the given instruction using noise cancelling headphones for the given instructions. For 11 minutes, an audio for Wim Hof breathing method that is as follow. * Take a strong inhalation through the nose. * Let out a relaxed exhalation through the mouth. * Repeat for 30 breaths. * On the 30th breath, exhale and hold your breath for 30 seconds in the first round then 1 minute in the 2nd round and 1 and a half minutes for the 3rd round. * Take a deep - Other Wim Hof Breathing Method
participants were asked to listen attentively to the given instruction using noise cancelling headphones for the given instructions. For 11 minutes, an audio for Wim Hof breathing method that is as follow. * Take a strong inhalation through the nose. * Let out a relaxed exhalation through the mouth. * Repeat for 30 breaths. * On the 30th breath, exhale and hold your breath for 30 seconds in the first round then 1 minute in the 2nd round and 1 and a half minutes for the 3rd round. * Take a deep
Primary outcome measures
- HEART RATE [Time frame: 12 weeks]
- Vo2 max [Time frame: 12 weeks]
Eligibility criteria
Inclusion criteria
- Males and females.
- Age range between 18 and 25 years.
- Adults who are healthy
Exclusion criteria
If they had:
- Any systemic disorders.
- Musculoskeletal, neuromuscular, or chronic respiratory conditions.
- Females were menstruating
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
Lebanon · 1 center
- BAU — Beirut
Identifiers
NCT: NCT07399119 · 2025-H-0237-HSC-R-0763 - BAU.